We provide solutions in specialty domains such as ophthalmology, epilepsy, intoxication management, anxiety and stem cells. Our products meet real needs and often fill therapeutic gaps. Fully committed to improving access to veterinary medicine, we develop and market innovative products and services that improve the well-being and health of dogs and cats, the practice of veterinarians and the peace of mind of owners.
The history of DÔMES PHARMA began after the Second World War with René Moulin, a pharmacist in Clermont Ferrand (France).
Passionate about animals, he anticipated the growing need for veterinary products for pets. At the back of his pharmacy, he developed a range of Moulin Veterinary Products which soon became locally renowned. In 1963, Simone Moulin, his wife, convinced him to go into industrial production. Simone MOULIN managed the company during 32 years.
In the 1970s, she was joined by her son Jean Moulin, who wanted to diversify the clientele by addressing the range to veterinarians.
In the 80s, René Moulin’s son, Jean Moulin bought a small phytotherapy company with his friend, Chantal Lugnier, also a pharmacist, then they bought the veterinary division of a pharma company specializing in human ophthalmology. They set themselves two major objectives: to meet the new regulatory requirements and to develop the sales team.
The 1990s and 2000s were marked by the ambitious construction of a drug manufacturing plant, EUROPHARTECH (1992) and the launch of flagship drugs for the TVM laboratory such as Vitamin K1 and Loperal.
With a background in management, administration and international business and three years spent in one of the Group’s subsidiaries, Anne Moulin, daughter of Jean Moulin, joined the Group’s management team in 2008 and became President of the EXCOM in 2016, with the aim of shaping the Group with her skills and vision. “We want to be an independent, international and multi-channel player in animal health”.
Accompanied by her management team, Anne Moulin focused on implementing her digital and international strategy and in 2016 offered the Group its first European subsidiary in the UK.
